VABYSMO J Code: J2777

Drug & Product Overview

HCPCS Descriptor Injection, faricimab-svoa, 0.1 mg

HCPCS Added Date October 1, 2022

Manufacturer Genentech

Route of Administration Intravitreal

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution

About VABYSMO

Vabysmo is a medication aligned to the HCPCS J Code: J2777 for billing, pricing, and reimbursement purposes in the United States. Classified under Ophthalmology, it is administered via the intravitreal route and manufactured by Genentech.

According to CMS Drug Use Information: Faricimab is used to treat certain serious eye conditions (such as wet age-related macular degeneration, macular edema). It is used to help prevent decreased vision and blindness. Faricimab works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
50242-0096-01	Vabysmo	Genentech, Inc.	60	6 MG / 0.05 ML
50242-0096-06	Vabysmo	Genentech, Inc.	60	6 MG / 0.05 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

VABYSMO Pricing & Reimbursement

J2777 Private Payer Reimbursement

$33.55 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

VABYSMO CPT Administration Codes

CPT Code	Description
67028	Intravitreal injection of a pharmacologic agent (separate procedure) 67028

JW / JZ modifiers apply

CMS has identified Vabysmo (J2777) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

VABYSMO Medically Unlikely Edits (MUE)

The most billing units of J2777 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.

Practitioner Office & Hospital Outpatient

120 units / day

= 12 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

VABYSMO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Diabetic Macular Edema (DME) Macular Edema Following Retinal Vein Occlusion (RVO) Neovascular (wet) Age-Related Macular Degeneration (nAMD)

Frequently Asked Questions

Is there an available Vabysmo billing and coding guide?

Billing and coding information for VABYSMO can be found through Genentech. Visit Here →

Are there any available Vabysmo patient assistance programs?

VABYSMO patient assistance information can be found through Genentech. Visit Here →

Where can I find Vabysmo prescribing information?

VABYSMO prescribing information can be found at the link below: Visit Here →

Where can I find Vabysmo side effect information?

Our team has not yet identified a source of side effects information for VABYSMO. Please check back in a few weeks.

Does billing VABYSMO require JZ/JW wastage modifiers?

CMS has identified VABYSMO(J2777) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.